Yue Zheng

Dr. Yue Zheng

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2024 in JMIR Medical Education
Verified
Journal Article
Open access
YWYijun Wu
Yijun Wu
YZYue Zheng
Yue Zheng
BFBaijie Feng
Baijie Feng
YYYuqi Yang
Yuqi Yang
KKKai Kang
Kai Kang
AZAilin Zhao
Ailin Zhao
ChatGPT (OpenAI), a cutting-edge natural language processing model, holds immense promise for revolutionizing medical education. With its remarkable performance in language-related tasks, ChatGPT offers personalized and efficient learning experiences for medical students and doctors. Through training, it enhances clinical reasoning and decision-making skills, leading to improved case analysis and diagnosis. The model facilitates simulated dialogues, intelligent tutoring, and automated question-answering, enabling the practical application of medical knowledge. However, integrating ChatGPT into medical education raises ethical and legal concerns. Safeguarding patient data and adhering to data protection regulations are critical. Transparent communication with students, physicians, and patients is essential to ensure their understanding of the technology’s purpose and implications, as well as the potential risks and benefits. Maintaining a balance between personalized learning and face-to-face interactions is crucial to avoid hindering critical thinking and communication skills. Despite challenges, ChatGPT offers transformative opportunities. Integrating it with problem-based learning, team-based learning, and case-based learning methodologies can further enhance medical education. With proper regulation and supervision, ChatGPT can contribute to a well-rounded learning environment, nurturing skilled and knowledgeable medical professionals ready to tackle health care challenges. By emphasizing ethical considerations and human-centric approaches, ChatGPT’s potential can be fully harnessed in medical education, benefiting both students and patients alike.

18 July 2023 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
YZYue Zheng
Yue Zheng
LWLaduona Wang
Laduona Wang
BFBaijie Feng
Baijie Feng
AZAilin Zhao
Ailin Zhao
YWYijun Wu
Yijun Wu

8 August 2023 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
YZYue Zheng
Yue Zheng
YWYijun Wu
Yijun Wu
BFBaijie Feng
Baijie Feng
LWLaduona Wang
Laduona Wang
KKKai Kang
Kai Kang
AZAilin Zhao
Ailin Zhao

4 June 2024 in International Journal of Surgery
Verified
Journal Article
Open access
YYYuqi Mbbs Yang
Yuqi Mbbs Yang
YZYue Zheng
Yue Zheng
XSXu Sun
Xu Sun
AZAilin Zhao
Ailin Zhao
YWYijun Wu
Yijun Wu
An abstract is unavailable. This article is available as a PDF only.

12 June 2024 in JMIR Cancer
Verified
Journal Article
Open access
YZYue Zheng
Yue Zheng
AZAilin Zhao
Ailin Zhao
YYYuqi Yang
Yuqi Yang
LWLaduona Wang
Laduona Wang
YHYifei Hu
Yifei Hu
YWYijun Wu
Yijun Wu
Background: Metachronous second primary lung cancer (MSPLC) is not that rare but is seldom studied. Objective: We aim to compare real-world survival outcomes between different surgery strategies and radiotherapy for MSPLC. Methods: This retrospective study analyzed data collected from patients with MSPLC between 1988 and 2012 in the Surveillance, Epidemiology, and End Results (SEER) database. Propensity score matching (PSM) analyses and machine learning were performed to compare variables between patients with MSPLC. Survival curves were plotted using the Kaplan-Meier method and were compared using log-rank tests. Results: A total of 2451 MSPLC patients were categorized into the following treatment groups: 864 (35.3%) received radiotherapy, 759 (31%) underwent surgery, 89 (3.6%) had surgery plus radiotherapy, and 739 (30.2%) had neither treatment. After PSM, 470 pairs each for radiotherapy and surgery were generated. The surgery group had significantly better survival than the radiotherapy group (P<.001) and the untreated group (563 pairs; P<.001). Further analysis revealed that both wedge resection (85 pairs; P=.004) and lobectomy (71 pairs; P=.002) outperformed radiotherapy in overall survival for MSPLC patients. Machine learning models (extreme gradient boosting, random forest classifier, adaptive boosting) demonstrated high predictive performance based on area under the curve (AUC) values. Least absolute shrinkage and selection operator (LASSO) regression analysis identified 9 significant variables impacting cancer-specific survival, emphasizing surgery’s consistent influence across 1 year to 10 years. These variables encompassed age at diagnosis, sex, year of diagnosis, radiotherapy of initial primary lung cancer (IPLC), primary site, histology, surgery, chemotherapy, and radiotherapy of MPSLC. Competing risk analysis highlighted lower mortality for female MPSLC patients (hazard ratio [HR]=0.79, 95% CI 0.71-0.87) and recent IPLC diagnoses (HR=0.79, 95% CI 0.73-0.85), while radiotherapy for IPLC increased mortality (HR=1.31, 95% CI 1.16-1.50). Surgery alone had the lowest cancer-specific mortality (HR=0.83, 95% CI 0.81-0.85), with sublevel resection having the lowest mortality rate among the surgical approaches (HR=0.26, 95% CI 0.21-0.31). The findings provide valuable insights into the factors that influence cumulative cancer-specific mortality. Conclusions: Surgical resections such as wedge resection and lobectomy confer better survival than radiation therapy for MSPLC, but radiation can be a valid alternative for the treatment of MSPLC.

8 May 2024 in International Journal of Surgery
Verified
Journal Article
Open access
YZYue Zheng
Yue Zheng
XSXu Sun
Xu Sun
KKKai Kang
Kai Kang
AZAilin Zhao
Ailin Zhao
YWYijun Wu
Yijun Wu
An abstract is unavailable. This article is available as a PDF only.